T47.1X4
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by other antacids and anti-gastric-secretion drugs, classified under ICD-10 code T47.1X4, refers to cases where individuals experience adverse effects due to the overdose or misuse of medications used to manage stomach acidity and related conditions. These medications include various antacids and drugs that reduce stomach acid secretion. While these medications are generally safe when used as directed, improper use can lead to toxic effects, which may require medical attention. This condition encompasses a broad range of unintended or accidental poisoning incidents involving these drugs, with clinical manifestations varying based on the substance and amount involved.
Causes & Symptoms
Clinical Causes: Overuse or overdose of antacids or anti-gastric-secretion medications Accidental ingestion, especially in children Intentional misuse or abuse of these medications Incorrect dosing due to misunderstanding of medication instructions Combination with other substances that increase toxicity
Key Symptoms: Gastrointestinal disturbances such as nausea, vomiting, or abdominal pain Signs of electrolyte imbalance, such as muscle weakness, irregular heartbeat, or confusion Altered mental status or drowsiness Respiratory difficulties in severe cases When involving specific drugs, symptoms may include dizziness, headache, or allergic reactions
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a review of the patient's medical history, including recent medication use and potential exposure. Laboratory tests such as blood chemistry panels can identify electrolyte imbalances or drug levels. Urinalysis and toxicology screenings may also be employed to detect the presence of specific substances. Clinical evaluation focuses on the severity of symptoms and the potential need for supportive care.
Treatment Protocols: Management of poisoning by antacids and anti-gastric-secretion drugs involves supportive care tailored to the severity of the symptoms. Interventions may include activated charcoal administration to limit drug absorption, intravenous fluids for dehydration and electrolyte correction, and medications to counteract specific symptoms or toxic effects. In severe cases, hospitalization might be necessary for monitoring and advanced interventions, such as hemodialysis if indicated. Prevention of future incidents involves counseling on proper medication use, storage, and awareness of potential risks.
Clinical Advice & FAQs
Billing Guidance
Is T47.1X4 a billable ICD-10 code?
Yes, T47.1X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T47.1X4?
Clinical documentation must specify the nature of Poisoning by other antacids and anti-gastric-secretion drugs, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference